Long-term effect of strontium ranelate treatment on BMD

被引：41

作者：

Blake, GM ^{[1
]}

Fogelman, G ^{[1
]}

机构：

[1] Guys Kings & St Thomas Sch Med, London, England

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 11期

关键词：

D O I：

10.1359/JBMR.050810

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1901 / 1904

页数：4

共 19 条

[1] Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures [J].

Black, DM ;

Cummings, SR ;

Karpf, DB ;

Cauley, JA ;

Thompson, DE ;

Nevitt, MC ;

Bauer, DC ;

Genant, HK ;

Haskell, WL ;

Marcus, R ;

Ott, SM ;

Torner, JC ;

Quandt, SA ;

Reiss, TF ;

Ensrud, KE .

LANCET, 1996, 348 (9041) :1535-1541

[2]

Boivin G, 1996, J BONE MINER RES, V11, P1302

[3] Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis [J].

Chesnut, CH ;

Skag, A ;

Christiansen, C ;

Recker, R ;

Stakkestad, JA ;

Hoiseth, A ;

Felsenberg, D ;

Huss, H ;

Gilbride, J ;

Schimmer, RC ;

Delmas, PD .

JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1241-1249

[4] Summary of meta-analyses of therapies for postmenopausal osteoporosis [J].

Cranney, A ;

Guyatt, G ;

Griffith, L ;

Wells, G ;

Tugwell, P ;

Rosen, C .

ENDOCRINE REVIEWS, 2002, 23 (04) :570-578

[5] Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial [J].

Cummings, SR ;

Black, DM ;

Thompson, DE ;

Applegate, WB ;

Barrett-Connor, E ;

Musliner, TA ;

Palermo, L ;

Prineas, R ;

Rubin, SM ;

Scott, JC ;

Vogt, T ;

Wallace, R ;

Yates, AJ ;

LaCroix, AZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (24) :2077-2082

[6] Incorporation and distribution of strontium in bone [J].

Dahl, SG ;

Allain, P ;

Marie, PJ ;

Mauras, Y ;

Boivin, G ;

Ammann, P ;

Tsouderos, Y ;

Delmas, PD ;

Christiansen, C .

BONE, 2001, 28 (04) :446-453

[7] Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate [J].

Eastell, R ;

Barton, I ;

Hannon, RA ;

Chines, A ;

Garnero, P ;

Delmas, PD .

JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) :1051-1056

[8] Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial [J].

Ettinger, B ;

Black, DM ;

Mitlak, BH ;

Knickerbocker, RK ;

Nickelsen, T ;

Genant, HK ;

Christiansen, C ;

Delmas, PD ;

Zanchetta, JR ;

Stakkestad, J ;

Glüer, CC ;

Krueger, K ;

Cohen, FJ ;

Eckert, S ;

Ensrud, KE ;

Avioli, LV ;

Lips, P ;

Cummings, SR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :637-645

[9] Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial [J].

Harris, ST ;

Watts, NB ;

Genant, HK ;

McKeever, CD ;

Hangartner, T ;

Keller, M ;

Chesnut, CH ;

Brown, J ;

Eriksen, EF ;

Hoseyni, MS ;

Axelrod, DW ;

Miller, PD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14) :1344-1352

[10] EFFECT OF ORAL ALENDRONATE ON BONE-MINERAL DENSITY AND THE INCIDENCE OF FRACTURES IN POSTMENOPAUSAL OSTEOPOROSIS [J].

LIBERMAN, UA ;

WEISS, SR ;

BROLL, J ;

MINNE, HW ;

QUAN, H ;

BELL, NH ;

RODRIGUEZPORTALES, J ;

DOWNS, RW ;

DEQUEKER, J ;

FAVUS, M ;

SEEMAN, E ;

RECKER, RR ;

CAPIZZI, T ;

SANTORA, AC ;

LOMBARDI, A ;

SHAH, RV ;

HIRSCH, LJ ;

KARPF, DB .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (22) :1437-1443

← 1 2 →